Literature DB >> 20692714

Psoriasis genetics: breaking the barrier.

Elisha D O Roberson1, Anne M Bowcock.   

Abstract

Psoriasis is a common incurable inflammatory skin disease affecting 2-3% of the European population. Psoriatic skin contains large numbers of immune cells which produce many cytokines, chemokines and inflammatory molecules. The epidermis divides much faster than normal and has a defective outer layer or barrier which under normal circumstances protects from infection and dehydration. Psoriatic skin is characterized by a distinct set of inflammation and epidermal proliferation and differentiation markers, and it has been unclear whether the genetic basis of psoriasis reflects defects of the immune system or of the skin. One genetic determinant lies within the major histocompatibility complex class 1 region. Genome-wide association studies have revealed genetic susceptibility factors that play a role in the formation of immune cells found in psoriasis lesions. Others affect epidermal proliferation and skin barrier formation. Hence, genetic components of both the immune system and the epidermis can predispose to disease. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692714      PMCID: PMC2957827          DOI: 10.1016/j.tig.2010.06.006

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  87 in total

1.  S100 protein subcellular localization during epidermal differentiation and psoriasis.

Authors:  Ann-Marie Broome; David Ryan; Richard L Eckert
Journal:  J Histochem Cytochem       Date:  2003-05       Impact factor: 2.479

2.  Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris.

Authors:  Yuichiro Tsunemi; Hidehisa Saeki; Koichiro Nakamura; Takashi Sekiya; Koichi Hirai; Hideki Fujita; Noriko Asano; Megumi Kishimoto; Yuka Tanida; Takashi Kakinuma; Hiroshi Mitsui; Yayoi Tada; Motoshi Wakugawa; Hideshi Torii; Mayumi Komine; Akihiko Asahina; Kunihiko Tamaki
Journal:  J Dermatol Sci       Date:  2002-11       Impact factor: 4.563

3.  Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris.

Authors:  J C Prinz; S Vollmer; W H Boehncke; A Menssen; I Laisney; P Trommler
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

4.  Interleukin 20: discovery, receptor identification, and role in epidermal function.

Authors:  H Blumberg; D Conklin; W F Xu; A Grossmann; T Brender; S Carollo; M Eagan; D Foster; B A Haldeman; A Hammond; H Haugen; L Jelinek; J D Kelly; K Madden; M F Maurer; J Parrish-Novak; D Prunkard; S Sexson; C Sprecher; K Waggie; J West; T E Whitmore; L Yao; M K Kuechle; B A Dale; Y A Chandrasekher
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

5.  CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling.

Authors:  S Hida; K Ogasawara; K Sato; M Abe; H Takayanagi; T Yokochi; T Sato; S Hirose; T Shirai; S Taki; T Taniguchi
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

6.  Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map.

Authors:  Duncan Hewett; Lena Samuelsson; Joanne Polding; Fredrik Enlund; Devi Smart; Kathryn Cantone; Chee Gee See; Sapna Chadha; Annica Inerot; Charlotta Enerback; Doug Montgomery; Chris Christodolou; Phil Robinson; Paul Matthews; Mary Plumpton; Jan Wahlstrom; Gunnar Swanbeck; Tommy Martinsson; Allen Roses; John Riley; Ian Purvis
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

7.  Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies.

Authors:  A M Bowcock; W Shannon; F Du; J Duncan; K Cao; K Aftergut; J Catier; M A Fernandez-Vina; A Menter
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

8.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.

Authors:  Xianghong Zhou; James G Krueger; Ming-Chih J Kao; Ed Lee; Fenghe Du; Alan Menter; Wing Hung Wong; Anne M Bowcock
Journal:  Physiol Genomics       Date:  2003-03-18       Impact factor: 3.107

9.  IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.

Authors:  Tamara Kopp; Petra Lenz; Concha Bello-Fernandez; Robert A Kastelein; Thomas S Kupper; Georg Stingl
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

10.  Dynamic alteration of human beta-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin.

Authors:  Wook-Kang Huh; Takashi Oono; Yoshinori Shirafuji; Hisanori Akiyama; Jirô Arata; Masakiyo Sakaguchi; Nam-Ho Huh; Keiji Iwatsuki
Journal:  J Mol Med (Berl)       Date:  2002-09-19       Impact factor: 4.599

View more
  77 in total

1.  Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases.

Authors:  Ellen H van den Bogaard; Geuranne S Tjabringa; Irma Joosten; Mieke Vonk-Bergers; Esther van Rijssen; Henk J Tijssen; Mirthe Erkens; Joost Schalkwijk; Hans J P M Koenen
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

2.  A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease.

Authors:  Jingran Zhou; Ruiqiong Wu; Anthony A High; Clive A Slaughter; David Finkelstein; Jerold E Rehg; Vanessa Redecke; Hans Häcker
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

3.  Lce1 Family Members Are Nrf2-Target Genes that Are Induced to Compensate for the Loss of Loricrin.

Authors:  Yosuke Ishitsuka; Aaron J Huebner; Robert H Rice; Peter J Koch; Vladislav V Speransky; Alasdair C Steven; Dennis R Roop
Journal:  J Invest Dermatol       Date:  2016-05-07       Impact factor: 8.551

4.  Skin fragility and impaired desmosomal adhesion in mice lacking all keratins.

Authors:  Janina Bär; Vinod Kumar; Wera Roth; Nicole Schwarz; Miriam Richter; Rudolf E Leube; Thomas M Magin
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

5.  Modelling epidermis homoeostasis and psoriasis pathogenesis.

Authors:  Hong Zhang; Wenhong Hou; Laurence Henrot; Sylvianne Schnebert; Marc Dumas; Catherine Heusèle; Jin Yang
Journal:  J R Soc Interface       Date:  2015-02-06       Impact factor: 4.118

Review 6.  Genetic pathways in disorders of epidermal differentiation.

Authors:  Vanessa Lopez-Pajares; Karen Yan; Brian J Zarnegar; Katherine L Jameson; Paul A Khavari
Journal:  Trends Genet       Date:  2012-11-08       Impact factor: 11.639

Review 7.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

8.  In-vivo imaging of psoriatic lesions with polarization multispectral dermoscopy and multiphoton microscopy.

Authors:  Dimitrios Kapsokalyvas; Riccardo Cicchi; Nicola Bruscino; Domenico Alfieri; Francesca Prignano; Daniela Massi; Torello Lotti; Francesco S Pavone
Journal:  Biomed Opt Express       Date:  2014-06-24       Impact factor: 3.732

Review 9.  MicroRNAs in normal and psoriatic skin.

Authors:  Jing Xia; Weixiong Zhang
Journal:  Physiol Genomics       Date:  2013-12-10       Impact factor: 3.107

10.  Phospholipase Cδ1 regulates p38 MAPK activity and skin barrier integrity.

Authors:  Kaori Kanemaru; Yoshikazu Nakamura; Kengo Totoki; Takatsugu Fukuyama; Madoka Shoji; Hisae Kaneko; Kanako Shiratori; Atsuko Yoneda; Takafumi Inoue; Yoichiro Iwakura; Kenji Kabashima; Kiyoko Fukami
Journal:  Cell Death Differ       Date:  2017-04-21       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.